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INTRODUCTION
Previous studies have demonstrated that myocardial injuries, 
such as myocardial infarction or radiofrequency catheter ab-
lation (RFCA), lead to cardiac nerve sprouting and sympa-
thetic hyper innervation in animal models.1-4 Such cardiac 
nerve sprouting and cardiac sympathetic hyper innervation 
have been documented to be related to sudden cardiac 
death5,6 or atrial fibrillation (AF).7 The nerve regeneration is 
triggered by the expression of nerve growth factor-β (NGF-β) 
gene in the non-neuronal cells around the injury site, conse-
quently raising plasma levels of NGF-β.8 Therefore, the in-
crease of the plasma level of NGF-β may indicate active nerve 
sprouting and generation. However, the relationship between 
the plasma level of NGF-β and cardiac autonomic nerve activ-
ity or arrhythmia in human heart has not yet been evaluated. 
Heart rate variability (HRV) is a measurement of the cyclic 
variation of the time intervals between consecutive normal 
heart beats, and has been widely used to assess cardiac auto-
nomic activity, and may be considered as a marker of sympa-
thetic and parasympathetic influence on the modulation of 
heart rate (HR). Therefore, HRV is one of the integral compo-
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nents of autonomic nervous system assessment.9 Extensive 
but titrated atrial tissue damage during catheter ablation of 
AF was known to increase trans-cardiac NGF concentration 
in patients with AF.10 However, it has not been elucidated 
whether the plasma level of NGF increases after RFCA and it 
may reflect post-procedural cardiac autonomic activity in pa-
tients who underwent AF catheter ablation. Therefore, we hy-
pothesized that RFCA for AF changes the plasma concentra-
tion of NGF-β, which is associated with 3rd month HRV or 
frequency of arrhythmias. We also tested the feasibility of 
double sandwich enzyme linked immunosorbent assay (ELI-
SA) technique for detection of the minimal change of NGF-β 
in the peripheral blood of patients with AF.
MATERIALS AND METHODS
Study population
The study protocol adhered to the Declaration of Helsinki and 
was approved by the Institutional Review Board of Yonsei 
University Health System. All patients provided written in-
formed consent. This study initially included consecutive 229 
patients with AF who underwent RFCA guided by computed 
tomography (CT) merged 3D NavX electroanatomical map. 
Exclusion criteria were as follows: 1) permanent AF refractory 
to the electrical cardioversion, 2) left atrial (LA) anterior pos-
terior dimension >55 mm measured on echocardiogram, 3) 
uncontrolled thyroid disease, 4) aortic aneurysm or dissec-
tion, 5) intracardiac thrombi detected by transesophageal 
echocardiography, 6) significant rheumatic valvular disease, 
or 7) previous AF ablation or maze surgery. Among 229 pa-
tients, 82 patients were excluded because one of HRV data 
(pre-RFCA, post-RFCA 3rd months, and post-RFCA 1 year) 
was not available due to frequent AF or other arrhythmias. We 
did not include the patients with cardiac implantable elec-
tronic device in this study. Finally, 147 patients with accept-
able 3 times of HRV data were included for data analysis. The 
baseline characteristics of the patients are summarized in Ta-
ble 1. All patients maintained optimal anticoagulation (target 
international normalized ratio 2.0–3.0) before the procedure 
and antiarrhythmic drugs (AADs) were discontinued for at 
least five half-lives of each drug and for at least 4 weeks espe-
cially in amiodarone. We examined all patients with 3D-spiral 
CT (64 Channel, Light Speed Volume CT, Philips, Brilliance 
63, the Netherlands) in order to visually define the anatomy of 
LA. 

















Male (%) 117 (79.6) 57 (78.1) 60 (81.1) 0.652 101 (79.5) 16 (80.0) 0.961 
Age, yrs 55.8±11.5 54.2±12.2 57.4±10.6 0.099 54.9±11.4 61.2±10.8 0.023 
PAF (%) 106 (72.1) 52 (71.2) 54 (73.0) 0.814 90 (70.9) 16 (80.0) 0.397 
AF duration, months 27.2±6.1 26.4±6.2 28.1±6.0 0.119 27.1±6.4 28.2±4.8 0.457 
CHADS2 score 0.80±1.03 0.82±1.00 0.77±1.07 0.763 0.76±1.04 1.00±0.97 0.344 
Heart failure (%) 0 (0.0) 0 (0.0) 0 (0.0) 1.000 0 (0.0) 0 (0.0) 1.000 
Hypertension (%) 62 (42.2) 31 (42.5) 31 (41.9) 0.944 52 (40.9) 10 (50.0) 0.446 
Age >75 yrs (%) 4 (2.7) 3 (4.1) 1 (1.4) 0.304 3 (2.4) 1 (5.0) 0.500 
Diabetes mellitus (%) 20 (13.6) 9 (12.3) 11 (14.9) 0.654 17 (13.4) 3 (15.0) 0.845 
Prior stroke or TIA (%) 15 (10.2) 8 (11.0) 7 (9.5) 0.764 12 (9.5) 3 (15.0) 0.446 
Body mass index (kg/m2) 25.0±2.5 24.9±2.7 25.0±2.4 0.887 25.1±2.5 23.9±2.6 0.048
Echocardiography
LA size, mm 41.3±5.4 41.6±5.9 41.1±5.0 0.646 41.0±5.3 43.4±5.8 0.067 
LVEF, % 63.8±6.9 63.5±7.3 64.2±6.6 0.559 63.8±7.1 64.0±5.8 0.926 
E/Em 10.1±3.6 10.0±4.0 10.3±3.2 0.604 10.0±3.6 10.6±4.1 0.506 
CT & NavX
LA volume index, mL/m2 64.0±19.2 66.6±19.5 61.3±18.8 0.114 62.5±18.6 73.2±21.2 0.028 
LA voltage, mV 1.23±0.56 1.23±0.58 1.22±0.53 0.912 1.21±0.56 1.30±0.56 0.534 
Clinical outcome
Ablation time, min 88.0±26.7 88.3±26.6 87.7±26.9 0.891 89.0±26.6 81.9±27.1 0.272 
Early recurrence (%) 39 (26.5) 19 (26.0) 20 (27.0) 0.891 35 (27.6) 4 (20.0) 0.477 
Clinical recurrence (%) 43 (29.3) 20 (27.4) 23 (31.1) 0.624 38 (29.9) 5 (25.0) 0.653 
Post-RFCA antiarrhythmic drugs (%) 42 (28.6) 24 (32.9) 18 (24.3) 0.251 35 (27.6) 7 (35.0) 0.494 
NGF-β, nerve growth factor-β; AF, atrial fibrillation; LA, left atrial; RFCA, radiofrequency catheter ablation.
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Electrophysiological mapping and 3D voltage 
mapping
Intracardiac electrograms were recorded using a Prucka Car-
dioLabTM Electrophysiology system (General Electric Health 
Care System Inc., Milwaukee, WI, USA). Double trans-septal 
punctures were performed and multi-view pulmonary veno-
grams were obtained. After obtaining trans-septal access, sys-
temic anticoagulation was achieved with intravenous heparin 
to maintain an activated clotting time of 350–400 sec. We gen-
erated 3D-spiral CT merged 3D electroanatomical mapping 
(NavX system, St. Jude Medical Inc., Minneapolis, MN, USA). 
We generated a LA 3D voltage map by obtaining contact bipo-
lar electrograms from 350–500 points of the LA endocardium 
during high right atrial pacing (pacing cycle length: 500 ms) 
using a multi-polar ring catheter (Lasso, Johnson & Johnson 
Inc., Diamond Bar, CA, USA). The bipolar electrograms were 
filtered from 32 to 300 Hz. Color-coded voltage maps were 
generated by recording bipolar electrograms and measuring 
peak-to-peak voltage. The percentage of color-coded areas of 
voltage maps was analyzed by customized software (Image 
Pro software 6.0, Media Cybernetics Inc., Silver Spring, MD, 
USA), referenced to the color scale bars, and utilized for the 
calculation of the mean and regional endocardial voltages.11 
AF ablation techniques
We used an open irrigated-tip catheter (Celsius, Johnson & 
Johnson Inc., Diamond Bar, CA, USA; irrigation flow rate 20 to 
30 mL/min; 30 W; 47°C) to deliver RF energy for ablation 
(Stockert generator, Biosense Webster Inc., Diamond Bar, CA, 
USA). Patients with both PAF and PeAF initially underwent 
circumferential pulmonary vein isolation (CPVI) and cavotri-
cuspid isthmus block. Following CPVI in PeAF patients, we 
generated an LA roof line, a posterior inferior line, and an LA 
anterior line, and confirmed bidirectional blocks by differen-
tial pacing.12 Depending on the operator’s decision, additional 
ablations for superior vena cava, non-PV foci or complex frac-
tionated electrogram were conducted. If AF persisted beyond 
the aforementioned ablation protocols for PAF or PeAF, we 
stopped the procedure after internal cardioversion. The end 
point of our procedure was the point of no immediate recur-
rence of AF after cardioversion with isoproterenol infusion (5 
µg/min). If there were non-PV foci under isoproterenol infu-
sion, we ablated them all.
Post-ablation management and follow-up schedule 
Patients were asked to visit the outpatient clinic 1 week, 1 
month, 3 months, 6 months, and 12 months after RFCA. AADs 
were stopped in all patients after procedure, but AAD was 
prescribed for patients with AF recurrence or highly symp-
tomatic ECG-documented frequent atrial premature beats. 
Warfarin was maintained for at least 2 months after RFCA. 
The Holter monitoring (24 hr or 48 hr) were evaluated at pre-
RFCA and 3, 6, 12, 18, and 24 months after RFCA following the 
HRS/EHRA/ECAS Expert Consensus Statement guidelines.13 
Patients were also advised to call a clinician or visit the outpa-
tient clinic if they experienced symptoms suggestive of an ar-
rhythmia and Holter (24- or 48-h) or event recorder was per-
formed to document ECG in those symptomatic patients. 
Patients with any documented AF episode lasting longer than 
30 sec after the 3-month follow-up were deemed as having 
clinical recurrence and AADs were prescribed. 
HRV analyses
All patients had analyzable HRV data in Holter monitoring 
taken at 3 different periods (pre-RFCA, post-RFCA 3rd month, 
and post-RFCA 1 year) by utilizing a GE Marquette MARS 8000 
Holter analyzer (GE Medical System, Milwaukee, WI, USA). 
We excluded the patients whose HRV was not analyzable due 
to sinus node dysfunction, high number of AF or other ar-
rhythmia episodes. Premature ventricular contractions 
(PVCs), atrial premature contractions (APCs), and electrical 
artifacts were also excluded from the analysis. Only high-
quality recordings were considered for analysis. All recordings 
were converted to a digitized format and reviewed by an ex-
perienced operator. HRV parameters were obtained and used 
as an indicator of autonomic activity according to the guide-
lines previously published.14 The mean HR, time-domain 
HRV parameters [mean RR interval (mean NN interval), the 
standard deviation of NN intervals (SDNN), the standard de-
viation of 5-minute means of NN intervals (SDANN), the root-
mean square of differences between successive NN intervals 
(rMSSD), the proportion of adjacent NN intervals differing by 
>50 ms (%) (pNN50)], frequency domain parameters [very-
low-frequency components (<0.04 Hz), low frequency com-
ponents (LF; 0.04–0.15 Hz), high-frequency components (HF; 
0.15–0.40 Hz), and the ratio of LF/HF] were analyzed, respec-
tively. The HF and rMSSD served as an indicator of parasym-
pathetic nervous activity, and the LF and LF/HF ratio reflect-
ed sympathetic nervous activity.
Statistical analysis
Continuous data were expressed as mean±SD and normality 
tests were performed for each variable to determine whether 
or not a data set was well-modeled by normal distribution. 
The baseline characteristics of the two groups were compared 
using the Student t-test for continuous variables and the chi-
square test and Fisher’s exact test for categorical variables. We 
analyzed HRV parameters in Holter monitoring according to 
the plasma levels of NGF-β before and after RFCA. Baseline 
characteristics and clinical variables associated with RFCA 
were also compared according to the plasma levels of NGF-β. 
Continuous variables were divided and assessed using the 
median value as the cut-off points. Statistical significance was 
established at a value of p<0.05. Statistical analysis was per-
formed by SPSS version 20.0 (SPSS Inc., Chicago, IL, USA). 
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RESULTS
AF ablation raises the NGF-βpost-1hr, but not in old 
patients with significant LA remodeling
The plasma levels of NGF-β significantly increased 1 hour af-
ter RFCA (20.1±11.1 pg/mL vs. 29.6±19.4 pg/mL, p<0.001) 
(Fig. 1A). There was a significant correlation between the 
plasma levels of pre-procedural NGF-β and post-procedural 
NGF-β (R=0.773, p<0.001) (Fig. 1B). Table 1 summarized the 
baseline characteristics of included patients, and there was no 
significant difference between the patients with NGF-βpre >18 
pg/mL (n=73) and those with ≤18 pg/mL (n=74) based on the 
median plasma level of NGF-β. When we compared the pa-
tients who had an increased plasma NGF-βpost-1hr (n=127) and 
those did not (n=20), the group with no increase of NGF-βpost-1hr 
showed older age (p=0.023), lower body mass index (p=0.048), 
and greater LA volume index (p=0.028) (Table 1). However, 
higher plasma levels of NGF-β were not related to longer du-
ration of total ablation time. In Post AF ablation, mean heart 
rate and LF was higher than before ablation. In contrast, rMS-
SD was higher in pre AF albation (Fig. 1C, D, and E).
High NGF-βpre and NGF-βpost-1hr are associated with 
high LF/HF and APC frequency in HRVpost-3mo
Fig. 2 summarized the changes of mean HR and HRV at pre-
RFCA (HRVpre), post-RFCA 3 months (HRVpost-3mo), and post-
RFCA 1 year (HRVpost-1yr), depending on median plasma levels 
of NGF-βpre and NGF-βpost-1hr. After catheter ablation of AF, 
mean HRs were increased at Holterpost-3mo (68.9±12.3 bpm to 
72.4±10.3 bpm, p=0.010) and at Holterpost-1yr (71.9±10.1 bpm, 
p=0.023). The rMSSD (27.1±22.9 ms to 20.6±15.8 ms, p=0.009 
and 20.7±14.8 ms, p=0.010), LF (16.4±19.3 Hz to 10.6±11.4 Hz, 
p=0.003 and 11.3±10.9 Hz, p=0.010) were reduced at HRVpost-
3mo and HRVpost-1yr, respectively. We compared HRV parame-
ters depending on the plasma level of NGF-βpre and NGF-βpost-
1hr using the median values as a cut-off (Table 2). Compared to 
the patients with NGF-βpre ≤18 pg/mL, NGF-βpre >18 pg/mL 
group showed higher LF/HF ratio (p=0.003) and higher num-
ber of APCs (p=0.045) in HRVpost-3mo (Fig. 2E and F). LF/HF ra-
tio was also higher in high NGF-βpost-1hr group than in low 
NGF-βpost-1hr group (p=0.042). Because both sympathetic (rep-
resented by LF) and parasympathetic (represented by rMSSD) 
activities were reduced after AF catheter ablation, we might 
not have found significant change of LF/HF ratio in the whole 
population (Fig. 2).
Fig. 1. (A) Plasma levels of NGF-β before and after AF ablation. (B) Correlation between pre- and post-ablation NGF-βs. (C) Mean heart rate in pre AF abla-
tion, post 3 month AF ablation, and post 1 year AF ablation. (D) rMSSD in pre AF ablation, post 3 month AF ablation, and post 1 year AF ablation. (E) LF in 
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High NGF-βpre and NGF-βpost-1hr are independently 
associated with high LF/HF in HRVpost-3mo
In the uni- and multi-variate linear regression analyses, both 
NGF-βpre (B=4.240, 95% CI 1.114–7.336, p=0.008) and NGF-
βpost-1hr (B=7.617, 95% CI 2.106–13.127, p=0.007) were linearly 
associated with LF/HF ratio at HRVpost-3mo (Table 3). Both the 
plasma levels of NGF-βpre (OR=1.159, 95% CI 1.045–1.286, 
p=0.005) and NGF-βpost-1hr (OR=1.098, 95% CI 1.030–1.170, 
p=0.004) were independently associated with the increase of 
LF/HF at HRVpost-3mo (Table 4). However, AF recurrence or ven-
tricular arrhythmic events did not vary depending on the 
plasma levels of NGF-β. 
DISCUSSION
The present study demonstrated that catheter ablation of AF 
increases the plasma level of NGF-β significantly, and NGF-β 
was closely associated with high sympathetic nerve activity 
estimated by HRV and high number of APCs in Holter per-
formed 3 months after the procedure. However, plasma level 
of NGF-β was not increased after RFCA in patients with old 
age and advanced LA remodeling. We also documented the 
feasibility of double sandwich ELISA technique for detection 
of the minimal change of NGF-β in the peripheral blood of 
patients with AF.
The role of plasma NGF-β in cardiac nerve sprouting 
after cardiac injury
Following a peripheral nerve injury, a complex and finely reg-
ulated sequence of events lead to neurilemma cell prolifera-
tion and axonal regeneration.15 Nerve regeneration is trig-
gered by re-expression of NGF or other neurotrophic factors 
in the non-neuronal cells around the site of injury.8 NGF and 
other neurotrophic factors that are derived from myocardial 
injuries are transported retrograde to the stellate ganglion, 
which triggers cardiac nerve sprouting in canine models.16 
Acute myocardial infarction causes an immediate (within 30 
minutes) increase of transcardiac NGF concentration, where-
as mRNA of NGF in the damaged myocardium begins to in-
crease 3 days after myocardial infarction and peaks 1 week 
later.16 NGF over-expression is associated with myocardial hy-
per innervation and atrial fibrosis,17 and heterogeneous in-
creases in atrial sympathetic innervation contribute to the 
Fig. 2. Changes of mean heart rate and HRV after catheter ablation of AF. We compared the change of Mean heart rate (A), rMSSD (B), LF (C), HF (D), LF/
HF ratio (E), and number of APCs (F) defending on the NGF-βpre plasma level. HRV, heart rate variability; AF, atrial fibrillation; HF, high-frequency compo-
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generation and maintenance of AF by exerting significant ef-
fects on automaticity, refractoriness, and conduction veloci-
ty.18-20 In this study, elevated NGF level was found to be associ-
ated with high sympathetic tone and high frequency of APCs 
after RFCA. 
Catheter ablation and NGF-β
RFCA is a kind of necrotic cardiac injury and induces cardiac 
nerve sprouting, which has been known to be related to the 
rises of the level of NGF.4,16 Kangavari, et al.10 demonstrated 
that RFCA induces over-expression of NGF mRNA, resulting 
in increased plasma level of NGF. Although study population 
and detection methods were different, the current study 
found consistent elevation of plasma level of NGF-β after 
RFCA, but, it was not the case in patients with old age, low 
body mass index, and high LA volume index. We applied the 
















Mean HR, beats/min  69.4±12.5 68.5±12.1 0.640 69.2±11.3 68.7±13.3 0.820 
APC, N 1300.8±2830.9 833.9±1953.8 0.246 1119.8±2733.6 1010.9±2100.8 0.787 
PVC, N 195.3±884.2 216.7±815.6 0.879 232.6±927.5 179.2±763.4 0.704 
rMSSD, ms 27.4±18.7 26.7±26.6 0.867 25.9±21.1 28.1±24.7 0.634 
HF 10.8±10.4 9.0±9.4 0.358 8.4±5.7 11.3±12.6 0.145 
LF/HF 1.36±0.68 1.31±0.94 0.796 1.36±0.72 1.31±0.91 0.732 
HRVpost-3mo
Mean HR, beats/min  72.6±11.0 72.2±9.8 0.816 72.2±10.2 72.6±10.5 0.816 
APC, N 1368.7±4398.6 319.0±796.5 0.045 1004.3±3863.8 674.0±2315.4 0.531 
PVC, N 140.0±487.8 176.6±1196.4 0.809 105.8±469.9 211.7±1208.4 0.484 
rMSSD, ms 20.9±15.3 20.3±16.4 0.822 20.2±14.7 21.1±17.0 0.739 
HF 8.3±7.1 7.5±6.4 0.492 7.8±6.9 8.0±6.7 0.903 
LF/HF 1.42±0.56 1.18±0.41 0.003 1.38±0.52 1.21±0.47 0.042 
HRVpost-1yr
Mean HR, beats/min  72.0±10.2 71.8±10.1 0.897 72.7±9.7 71.2±10.5 0.389 
APC, N 1145.9±3068.7 490.8±1551.7 0.104 738.6±2473.9 894.7±2420.7 0.700 
PVC, N 108.0±343.8 51.9±179.3 0.216 67.7±254.1 92.0±294.3 0.592 
rMSSD, ms 19.3±10.4 22.2±18.5 0.273 18.4±7.9 23.2±19.7 0.063 
HF 8.1±6.3 8.1±6.5 0.973 7.1±3.9 9.1±8.1 0.074 
LF/HF 1.42±0.49 1.37±0.44 0.540 1.42±0.50 1.36±0.44 0.484 
HRV, heart rate variability; NGF-β, nerve growth factor-β; APC, atrial premature contraction; PVC, premature ventricular contraction; HR, heart rate; HF, high-fre-
quency components; LF, low frequency components.
Table 3. Uni- and Multivariate Linear Regression Analyses for Pre-NGF-β, Post-NGF-β1hr, and the Increase of NGF-β1hr
Univariate analysis Multivariate analysis
B 95% CI p value B 95% CI p value
NGF-βpre
HRVpre
PVC, N 0.003 0.001–0.005 0.008 0.000 -0.003–0.002 0.871 
HRVpost-3mo
LF/HF 4.234 1.150–7.319 0.007 4.240 1.114–7.336 0.008 
NGF-βpost-1hr
HRVpre
PVC, N 0.005 0.001–0.008 0.011 -0.002 -0.007–0.002 0.304 
HRVpost-3mo
LF/HF 9.141 3.516–14.765 0.002 7.617 2.106–13.127 0.007 
Increase of NGF-βpost-1hr
HRVpost-3mo
LF/HF 4.906 0.235–9.577 0.040 
NGF-β, nerve growth factor-β; HRV, heart rate variability; PVC, premature ventricular contraction; HF, high-frequency components; LF, low frequency components.
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double sandwich ELISA method to enhance detection sensi-
tivity to pg/mL level, and our results of plasma NGF-β level 
were consistent with other previous reports.21-23 Because AF 
catheter ablation itself has the effects of cardiac autonomic 
denervation,24 the change of post-ablation HRV cannot be the 
result of increased plasma level of NGF-β alone. However, the 
current study found that plasma level of NGF-β was clearly as-
sociated with the change of autonomic nerve activity at HRV-
post-3mo and HRVpost-1yr. 
AF and HRV
HRV relies on the principle that the pattern of beat-to-beat 
control of the sinoatrial node provides a reflection of cardiac 
autonomic nerve activity.14 Among multiple parameters in 
HRV, HF components are thought to primarily reflect vagal 
tone, whereas high LF/HF ratio has been assumed as the in-
dex of high sympathetic activity that is known to be pro-ar-
rhythmic and higher frequency of PVCs or APCs.14,25 The pres-
ent study showed that patients with a higher plasma level of 
NGF-β had a higher LF/HF ratio and a trend of more frequent 
APCs in Holter monitoring at 3 months after ablation. Al-
though NGF provokes both sympathetic and parasympathetic 
nerve regeneration, it was associated only with an increased 
sympathetic nerve activity, but not with an increased para-
sympathetic nerve activity in this study. This finding may be 
due to the fact that RFCA destroyed parasympathetic post-
ganglionic cells that are located at or very close to the ablation 
sites. On the other hand, since sympathetic postganglionic 
cells are located in the stellate ganglia far from the ablation 
site, ablation-induced sympathetic nerve axonal damage 
might recover three months after RFCA. It has been reported 
that a rapid HR after AF catheter ablation predicts a low recur-
rence rate of AF.26 Although it might be associated with an ap-
propriate vagal denervation, a high plasma level of NGF-β and 
an increased post-procedure LF/HF ratio in patients who 
have less remodeled atrium might contribute to a rapid HR 
and low recurrence after RFCA.
Study limitations
The present study has several limitations. The patients includ-
ed in this study were a highly selected group referred for 
RFCA, and the number of patients was also limited. We ex-
cluded patients with LA >55 mm. HRV analysis requires nor-
mal sinus rhythm with normal cardiac function, therefore, we 
excluded patients whose Holter could not be analyzed for 
HRV. We did not evaluate the long-term change in plasma 
level of NGF-β after AF ablation. Although we could not find 
statistical difference of clinical recurrence rate depending on 
the plasma levels of NGF-β in this small sample size and short 
follow-up period study, we found the differences in the LF/
HF at HRVpost-3mo. Recently, we reported that LF/HF at HRVpost-
3mo is an independent factor predicting clinical recurrence of 
AF after RFCA.27 We also found higher LF/HF ratio in HRVpost-
3mo and higher number of APCs in patients with NGF-βpre>18 
pg/mL than those with ≤18 pg/mL, but we do not have direct 
evidence for the mechanism or causal-results relationship. 
Further study with a large population may be warranted. We 
chose post-procedure 1 hour to evaluate the plasma level of 
NGF-βpost-1hr, but it might not be enough time to show in-
creased plasma level of NGF-β after RFCA. Because we used 
irrigated tip ablation catheter, irrigated fluid volume might af-
fect the plasma concentration of NGF-β.
In conclusion, AF catheter ablation increases plasma level 
of NGF-β, and high plasma levels of pre- or post-RFCA NGF-β 
were associated with high sympathetic nerve activity and the 
presence of high number of APCs in post-RFCA 3 month 
Holter. Double sandwich ELISA technique was feasible and 
acceptable for the detection of the minimal change of NGF-β 
in the peripheral blood of the patients with AF.
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